InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant
Groningen, The Netherlands, September 11, 2020, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...
Read moreInnoCore Pharmaceuticals to join Bill & Melinda Gates Foundation supported consortium to develop long-acting microneedle contraceptive 
Groningen, The Netherlands, January 15th, 2019, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...
Read moreMerck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology
Groningen, The Netherlands, July 26, 2018 – InnoCore Pharmaceuticals and Merck KGaA (operating as MilliporeSigma...
Read moreInnoCore renewed the GMP certificate
Groningen, February 6th, 2018: InnoCore Pharmaceuticals renewed the GMP certificate including laboratory authorization...
Read moreInnoCore has been awarded with the "Groningen Ondernemingsprijs 2017"
Groningen, 30th November 2017. With the development of long-term active medicines, InnoCore Pharmaceuticals has won the Groningen...
Read moreExclusive License Agreement with Allergan
Groningen, October 22, 2013: InnoCore Pharmaceuticals Enters into Exclusive License Agreement with Allergan Related to...
Read more